Condition

HPV16 Positive (2)

Cervical Intraepithelial Neoplasia (CIN 2/3) (1)

Squamous Cell Carcinoma of the Oropharynx (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

ISA Pharmaceuticals (1)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

Collaborator

National Cancer Institute (NCI) (1)

National Institutes of Health (NIH) (1)

Regeneron Pharmaceuticals (1)

Intervention

cemiplimab (1)

dna vaccination (1)

gene gun vaccine (1)

imiquimod (1)

intra-lesional vaccine administration (1)

intramuscular vaccination (1)

isa101b (1)

placebo (1)

therapeutic resection of the lesion (1)

Study Documents

Intervention Type

biological (2)

drug (2)

device (1)

other (1)

procedure (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

hpv16 positive

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Squamous Cell Carcinoma of the Oropharynx, HPV16 Positive Trial in Worldwide (biological, drug, other)

Recruiting

Squamous Cell Carcinoma of the Oropharynx
HPV16 Positive

ISA101b
+2 more

Duarte, California
+75 more

Sep 25, 2022

HPV16 Positive, Cervical Intraepithelial Neoplasia (CIN 2/3) Trial in Birmingham, Baltimore (biological, device, procedure,

Completed

Has Results

HPV16 Positive
Cervical Intraepithelial Neoplasia (CIN 2/3)

DNA vaccination
+5 more

Birmingham, Alabama
+2 more

Jul 6, 2018